Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10019173HBVENSG00000120907.18protein_codingADRA1ANoNo148B0ZBD3
P35348
TVIS10019323HBVENSG00000120907.18protein_codingADRA1ANoNo148B0ZBD3
P35348
TVIS10031044HBVENSG00000120907.18protein_codingADRA1ANoNo148B0ZBD3
P35348
TVIS10025139HBVENSG00000120907.18protein_codingADRA1ANoNo148B0ZBD3
P35348
TVIS10020261HBVENSG00000120907.18protein_codingADRA1ANoNo148B0ZBD3
P35348
TVIS10040464HBVENSG00000120907.18protein_codingADRA1ANoNo148B0ZBD3
P35348
TVIS20001928HPVENSG00000120907.18protein_codingADRA1ANoNo148B0ZBD3
P35348
TCGA Plot Options
Drug Information
GeneADRA1A
DrugBank IDDB01403
Drug NameMethotrimeprazine
Target IDBE0000501
UniProt IDP35348
Regulation Typeantagonist
PubMed IDs15701205; 2870716
CitationsGreen B, Pettit T, Faith L, Seaton K: Focus on levomepromazine. Curr Med Res Opin. 2004 Dec;20(12):1877-81.@@Dahl SG, Hough E, Hals PA: Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, alpha adrenergic and muscarinic cholinergic receptor binding. Biochem Pharmacol. 1986 Apr 15;35(8):1263-9.
GroupsApproved; Investigational
Direct ClassificationPhenothiazines
SMILESCOC1=CC2=C(SC3=C(C=CC=C3)N2C[C@H](C)CN(C)C)C=C1
Pathways
PharmGKBPA164743234
ChEMBLCHEMBL1764